Heart Failure and the management
of the prevalent non-heart failure
cancer-related Cardiovascular Toxicities.
Heart Failure(HF) occurs when our heart fails to pump blood as it
should pump. It is one of the largest cause of morbidity and health care
expenditure in the world and it continues to increase at an alarming rate. Most
of the increasing problems is related to the rapidly increseaing population of
HF with preserved ejection fraction, largely driven by the increasing rates of
obesity, hypertension. In the last few years, there have be tremendous advanced treatment of patients with HF with reduced ejection
fraction. Heart failure affects patients depending on their age. The recent
study tells that the young patients with heart failure has lower risk of death
but can have a poorer quality of life.
Cardio-oncology is the cardiovascular care of cancer
patients is a new approach to improve prevention, early identification and
management of cardio toxicity. In the recent years most of the focus has been
on the detection and prevention of heart failure, cancer therapies are
associated with a very broad range of cardiovascular toxicities which includes cardiac
arrhythmias, hypertension and ischemic heart disease.
No comments:
Post a Comment